recombinant-protein-expression-systems-challenges-opportunities3
FAQ's
Answer : Precedence Research Predicts, the global cardiovascular devices market was worth at US$ 49.8 billion in 2020 and is predicted to reach over US$ 92.51 billion by 2030.
Answer : The global cardiovascular devices market is growing at a CAGR of 6.4% during the forecast period 2021 to 2030.
Answer : The rising prevalence of various chronic cardiovascular diseases such as coronary artery disease, heart failure, and cardiac arrhythmia is fueling the growth of the cardiovascular devices market.
Answer : The major players operating in the cardiovascular devices market are B Braun Melsungen AG, Abbott, Johnson & Johnson Services, Inc., Medtronic, Boston Scientific Corporation, LivaNova Plc, Edwards Lifesciences Corporation, GE Healthcare, Siemens Healthcare GmbH, Terumo Cardiovascular Systems Corporation.
Answer : North America dominated the global cardiovascular devices in 2020. The increased prevalence of cardiovascular diseases in US has exponentially contributed towards the market growth in the past few years.
Get a Sample of this Report
recombinant-protein-expression-systems-challenges-opportunities3
